22157.jpg
Theranostics Global Market Report 2024: Market Projected to Reach $164.38 Billion by 2028, Driven by Advances in Cancer Treatment and Precision Medicine
January 25, 2024 09:36 ET | Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Theranostics Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global theranostics market forecast reveals...
22157.jpg
Global Genomic Collaboration and Licensing Agreements Analysis Report 2023: Access to Upfront, Milestone, Royalties Data, Broken Down by Company A-Z, Deal Type and Therapy Area
November 17, 2023 06:58 ET | Research and Markets
Dublin, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The "Genomic Collaboration and Licensing Deals 2016-2023" report has been added to ResearchAndMarkets.com's offering.This report contains a comprehensive...
Global Radiopharmaceutical Theranostics Market
Radiopharmaceutical Theranostics Market Projected to Reach $3.44 Billion by 2028, Fueled by Growing Cancer Incidence and Personalized Medicine
September 18, 2023 07:48 ET | Research and Markets
Dublin, Sept. 18, 2023 (GLOBE NEWSWIRE) -- The "Radiopharmaceutical Theranostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, Radioisotope, Source, Application,...
ITM_Roger Estafanos_General Manager ITM US
ITM Appoints Roger Estafanos as U.S. General Manager and Expands Presence with Opening of U.S. Headquarters in Princeton, New Jersey
April 17, 2023 08:03 ET | ITM Isotope Technologies Munich SE
Garching / Munich and Princeton, NJ, April 17, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical theranostics company, today announced that the company has opened its U.S....
MicrosoftTeams-image (5).png
Radiopharmaceutical Theranostics Market Size to Cross USD 12.4 Bn by 2031 | Transparency Market Research
April 03, 2023 17:30 ET | Transparency Market Research
Wilmington, Delaware, United States, April 04, 2023 (GLOBE NEWSWIRE) -- The global radiopharmaceutical theranostics market was valued at USD 3.0 Bn in 2022 and is projected to reach USD 12.4 Bn by...
TIP_link_300x300.jpg
Radiopharmaceutical Theranostics Market Worth $3.44 Billion, Globally, by 2028 at 11.3% CAGR | The Insight Partners
March 29, 2023 10:15 ET | The Insight Partners
Pune, India, March 29, 2023 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on "Radiopharmaceutical Theranostics Market Size, Share, Revenue, Growth Strategy, Industry...
ITM at ENETS
ITM to Present Phase III COMPOSE Poster and Host Satellite Symposium on Radiotheranostics in NET cancer at ENETS Conference
March 16, 2023 09:48 ET | ITM Isotope Technologies Munich SE
Garching / Munich, March 16, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical theranostics company, today announced that the company will present an overview of genetic...
ITM_Logo_Claim_RGB_high-res.png
ITM and BAMF Health Enter Global Cooperation Agreement for Targeted Radiopharmaceuticals in U.S. Radiopharmacy and Clinic Network
September 08, 2022 05:00 ET | ITM Isotope Technologies Munich SE
Garching / Munich, Germany, and Grand Rapids, MI, U.S., September 08, 2022 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and BAMF (Bold Advanced Medical...
22157.jpg
Global Genomics Partnering Deal Terms and Agreements Report/Directory 2022: Access to 900+ Deals Entered into by the World's Leading Healthcare Companies
September 05, 2022 06:58 ET | Research and Markets
Dublin, Sept. 05, 2022 (GLOBE NEWSWIRE) -- The "Global Genomics Partnering Terms and Agreements 2015 to 2022" report has been added to ResearchAndMarkets.com's offering.Access to 900+ Genomics...
ITM_Logo_Claim_RGB_high-res.png
ITM Acquires a New Platform for the Development of Next-Generation Theranostics
August 18, 2022 05:18 ET | ITM Isotope Technologies Munich SE
• Technology platform for PET tracers strengthens ITM’s radiodiagnostic portfolio • Additional assets potentially expand ITM’s pipeline of novel targeted radionuclide therapeutics Garching /...